{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T01:31:41Z","timestamp":1774747901711,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_212766"],"award-info":[{"award-number":["310030_212766"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_192648"],"award-info":[{"award-number":["310030_192648"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"Chinese Scholarship Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004361","name":"Krebsliga Schweiz","doi-asserted-by":"publisher","award":["KFS-4851-08-2019"],"award-info":[{"award-number":["KFS-4851-08-2019"]}],"id":[{"id":"10.13039\/501100004361","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stiftung zur Krebsbek\u00e4mpfung"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogenesis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Pleural mesothelioma (PM) is an aggressive, asbestos-linked cancer with limited treatment options and a poor prognosis. Lactate dehydrogenase B (LDHB) converts lactate to pyruvate, and its silencing reduces mitochondrial metabolism, particularly nucleotide synthesis. However, whether and a role of LDHB in PM is unclear. This study aimed to investigate the effects of silencing LDHB in PM cells and their response to chemotherapy. LDHB was silenced using siRNA transfection and inducible shRNA constructs. Proliferation, colony formation, and cell viability were assessed, while DNA damage was analyzed through \u0263H2AX levels. Compared to normal mesothelial cells, LDHB was highly expressed in PM cell lines. LDHB inhibition significantly reduced proliferation, cell viability, and colony formation, indicating its crucial role in PM cells. Additionally, LDHB silencing significantly increased nuclear DNA damage accumulation as indicated by elevated \u0263H2AX levels, which was reversed by nucleotide supplementation. In vivo, LDHB inhibition reduced tumor growth and enhanced cisplatin\u2019s therapeutic efficacy. LDHB silencing increased \u0263H2AX levels, which were further elevated with cisplatin treatment. Our results highlight LDHB as a novel therapeutic target in PM, where its inhibition induces DNA damage and improves the efficacy of cisplatin therapy.<\/jats:p>","DOI":"10.1038\/s41389-025-00571-4","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T16:12:36Z","timestamp":1754928756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inhibition of LDHB triggers DNA damage and increases cisplatin sensitivity in pleural mesothelioma"],"prefix":"10.1038","volume":"14","author":[{"given":"Yantang","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christelle","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tereza","family":"Losmanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2661-200X","authenticated-orcid":false,"given":"Samuel Oevg\u00fc","family":"Yasmin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Reymond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1199-6520","authenticated-orcid":false,"given":"Ren-Wang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Dorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3005-220X","authenticated-orcid":false,"given":"Thomas Michael","family":"Marti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"571_CR1","doi-asserted-by":"publisher","first-page":"F1000","DOI":"10.12688\/f1000research.15796.1","volume":"7","author":"L Berzenji","year":"2018","unstructured":"Berzenji L, Van Schil P. Multimodality treatment of malignant pleural mesothelioma. F1000Research. 2018;7:F1000 Faculty Rev-1681.","journal-title":"F1000Research"},{"key":"571_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/14728214.2021.1924670","volume":"26","author":"AP Davis","year":"2021","unstructured":"Davis AP, Kao SC, Clarke SJ, Boyer M, Pavlakis N. Emerging biological therapies for the treatment of malignant pleural mesothelioma. Expert Opin Emerg Drugs. 2021;26:179\u201392.","journal-title":"Expert Opin Emerg Drugs"},{"key":"571_CR3","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ccell.2016.08.005","volume":"30","author":"L Brisson","year":"2016","unstructured":"Brisson L, Ba\u0144ski P, Sboarina M, Dethier C, Danhier P, Fontenille M-J, et al. Lactate dehydrogenase B controls lysosome activity and autophagy in cancer. Cancer Cell. 2016;30:418\u201331.","journal-title":"Cancer Cell"},{"key":"571_CR4","first-page":"4831","volume":"8","author":"C Li","year":"2016","unstructured":"Li C, Chen Y, Bai P, Wang J, Liu Z, Wang T, et al. LDHB may be a significant predictor of poor prognosis in osteosarcoma. Am J Transl Res. 2016;8:4831\u201343.","journal-title":"Am J Transl Res"},{"key":"571_CR5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/1878-0261.12408","volume":"13","author":"L Shi","year":"2019","unstructured":"Shi L, Yan H, An S, Shen M, Jia W, Zhang R, et al. SIRT5-mediated deacetylation of LDHB promotes autophagy and tumorigenesis in colorectal cancer. Mol Oncol. 2019;13:358\u201375.","journal-title":"Mol Oncol"},{"key":"571_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00018-022-04453-5","volume":"79","author":"H Deng","year":"2022","unstructured":"Deng H, Gao Y, Trappetti V, Hertig D, Karatkevich D, Losmanova T, et al. Targeting lactate dehydrogenase B-dependent mitochondrial metabolism affects tumor initiating cells and inhibits tumorigenesis of non-small cell lung cancer by inducing mtDNA damage. Cell Mol Life Sci. 2022;79:23.","journal-title":"Cell Mol Life Sci"},{"key":"571_CR7","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41571-022-00686-2","volume":"19","author":"G Claps","year":"2022","unstructured":"Claps G, Faouzi S, Quidville V, Chehade F, Shen S, Vagner S, et al. The multiple roles of LDH in cancer. Nat Rev Clin Oncol. 2022;19:749\u201362.","journal-title":"Nat Rev Clin Oncol"},{"key":"571_CR8","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s42255-024-00993-1","volume":"6","author":"RG Leija","year":"2024","unstructured":"Leija RG, Curl CC, Arevalo JA, Osmond AD, Duong JJ, Huie MJ, et al. Enteric and systemic postprandial lactate shuttle phases and dietary carbohydrate carbon flow in humans. Nat Metab. 2024;6:670\u20137.","journal-title":"Nat Metab"},{"key":"571_CR9","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003;21:2636\u201344.","journal-title":"J Clin Oncol"},{"key":"571_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41568-022-00518-6","volume":"23","author":"W Hong","year":"2023","unstructured":"Hong W, Zeng X, Wang H, Tan X, Tian Y, Hu H, et al. Leveraging the replication stress response to optimize cancer therapy. Nat Rev Cancer. 2023;23:6\u201324.","journal-title":"Nat Rev Cancer"},{"key":"571_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nprot.2008.226","volume":"4","author":"J Friedrich","year":"2009","unstructured":"Friedrich J, Seidel C, Ebner R, Kunz-Schughart LA. Spheroid-based drug screen: considerations and practical approach. Nat Protoc. 2009;4:309\u201324.","journal-title":"Nat Protoc"},{"key":"571_CR12","doi-asserted-by":"publisher","first-page":"8893","DOI":"10.18632\/oncotarget.2360","volume":"5","author":"A Kharbanda","year":"2014","unstructured":"Kharbanda A, Rajabi H, Jin C, Alam M, Wong KK, Kufe D. MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells. Oncotarget. 2014;5:8893\u2013905.","journal-title":"Oncotarget"},{"key":"571_CR13","doi-asserted-by":"crossref","unstructured":"Berezowska S, Galv\u00e1n JA. Immunohistochemical detection of the autophagy markers LC3 and p62\/SQSTM1 in formalin-fixed and paraffin-embedded tissue. In: Pellicciari C, Biggiogera M, editors. Histochemistry of single molecules. New York, NY: Springer New York; 2017. p. 189\u201394.","DOI":"10.1007\/978-1-4939-6788-9_13"},{"key":"571_CR14","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1021\/acs.bioconjchem.9b00403","volume":"30","author":"M Heitz","year":"2019","unstructured":"Heitz M, Javor S, Darbre T, Reymond J-L. Stereoselective pH responsive peptide dendrimers for siRNA transfection. Bioconjugate Chem. 2019;30:2165\u201382.","journal-title":"Bioconjugate Chem"},{"key":"571_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2199-12-27","volume":"12","author":"A Fiszer-Kierzkowska","year":"2011","unstructured":"Fiszer-Kierzkowska A, Vydra N, Wysocka-Wycisk A, Kronekova Z, Jarz\u0105b M, Lisowska KM, et al. Liposome-based DNA carriers may induce cellular stress response and change gene expression pattern in transfected cells. BMC Mol Biol. 2011;12:27.","journal-title":"BMC Mol Biol"},{"key":"571_CR16","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.3390\/molecules23102564","volume":"23","author":"T Wang","year":"2018","unstructured":"Wang T, Larcher L, Ma L, Veedu R. Systematic screening of commonly used commercial transfection reagents towards efficient transfection of single-stranded oligonucleotides. Molecules. 2018;23:2564.","journal-title":"Molecules"},{"key":"571_CR17","doi-asserted-by":"publisher","first-page":"498","DOI":"10.4161\/cc.8.3.7701","volume":"8","author":"D Wiederschain","year":"2009","unstructured":"Wiederschain D, Susan W, Chen L, Loo A, Yang G, Huang A, et al. Single-vector inducible lentiviral RNAi system for oncology target validation. Cell Cycle. 2009;8:498\u2013504.","journal-title":"Cell Cycle"},{"key":"571_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-019-1037-1","volume":"19","author":"Y Gao","year":"2019","unstructured":"Gao Y, Dorn P, Liu S, Deng H, Hall SRR, Peng R-W, et al. Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment. Cancer Cell Int. 2019;19:317.","journal-title":"Cancer Cell Int"},{"key":"571_CR19","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.devcel.2022.06.003","volume":"57","author":"R Donne","year":"2022","unstructured":"Donne R, Saroul-Ainama M, Cordier P, Hammoutene A, Kabore C, Stadler M, et al. Replication stress triggered by nucleotide pool imbalance drives DNA damage and cGAS-STING pathway activation in NAFLD. Dev Cell. 2022;57:1728\u201341.e1726.","journal-title":"Dev Cell"},{"key":"571_CR20","doi-asserted-by":"publisher","first-page":"9891","DOI":"10.1073\/pnas.0603779103","volume":"103","author":"TM Marti","year":"2006","unstructured":"Marti TM, Hefner E, Feeney L, Natale V, Cleaver JE. H2AX phosphorylation within the G 1 phase after UV irradiation depends on nucleotide excision repair and not DNA double-strand breaks. Proc Natl Acad Sci USA. 2006;103:9891\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"571_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2117-4","volume":"16","author":"CC Tieche","year":"2016","unstructured":"Tieche CC, Peng RW, Dorn P, Froment L, Schmid RA, Marti TM. Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT. BMC Cancer. 2016;16:125.","journal-title":"BMC Cancer"},{"key":"571_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41420-023-01307-2","volume":"9","author":"H Yang","year":"2023","unstructured":"Yang H, Gao Y, Xu D, Xu K, Liang SQ, Yang Z, et al. MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma. Cell Death Discov. 2023;9:55.","journal-title":"Cell Death Discov"},{"key":"571_CR23","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.molonc.2014.07.008","volume":"8","author":"IN Kotov","year":"2014","unstructured":"Kotov IN, Siebring-van Olst E, Knobel PA, van der Meulen-Muileman IH, Felley-Bosco E, van Beusechem VW, et al. Whole genome RNAi screens reveal a critical role of REV3 in coping with replication stress. Mol Oncol. 2014;8:1747\u201359.","journal-title":"Mol Oncol"},{"key":"571_CR24","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1038\/sj.onc.1209607","volume":"25","author":"M Brandon","year":"2006","unstructured":"Brandon M, Baldi P, Wallace DC. Mitochondrial mutations in cancer. Oncogene. 2006;25:4647\u201362.","journal-title":"Oncogene"},{"key":"571_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s42255-023-00963-z","volume":"6","author":"M Demicco","year":"2024","unstructured":"Demicco M, Liu X-Z, Leithner K, Fendt S-M. Metabolic heterogeneity in cancer. Nat Metab. 2024;6:18\u201338.","journal-title":"Nat Metab"},{"key":"571_CR26","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/S0002-9440(10)62492-3","volume":"166","author":"GJ Gordon","year":"2005","unstructured":"Gordon GJ, Rockwell GN, Jensen RV, Rheinwald JG, Glickman JN, Aronson JP, et al. Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling. Am J Pathol. 2005;166:1827\u201340.","journal-title":"Am J Pathol"},{"key":"571_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-016-0346-x","volume":"16","author":"P Dorn","year":"2016","unstructured":"Dorn P, Ti\u00e8che CC, Peng R-W, Froment L, Schmid RA, Marti TM. Schedule-dependent increased efficiency of pemetrexed-ionizing radiation combination therapy elicits a differential DNA damage response in lung cancer cells. Cancer Cell Int. 2016;16:66.","journal-title":"Cancer Cell Int"},{"key":"571_CR28","doi-asserted-by":"publisher","first-page":"11949","DOI":"10.3390\/ijms231911949","volume":"23","author":"D Karatkevich","year":"2022","unstructured":"Karatkevich D, Deng H, Gao Y, Flint E, Peng R-W, Schmid RA, et al. Schedule-dependent treatment increases chemotherapy efficacy in malignant pleural mesothelioma. Int J Mol Sci. 2022;23:11949.","journal-title":"Int J Mol Sci"},{"key":"571_CR29","first-page":"867","volume":"138","author":"J Gerdes","year":"1991","unstructured":"Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol. 1991;138:867\u201373.","journal-title":"Am J Pathol"},{"key":"571_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40170-019-0196-9","volume":"7","author":"M Rosso","year":"2019","unstructured":"Rosso M, Lapyckyj L, Besso MJ, Monge M, Revent\u00f3s J, Canals F, et al. Characterization of the molecular changes associated with the overexpression of a novel epithelial cadherin splice variant mRNA in a breast cancer model using proteomics and bioinformatics approaches: identification of changes in cell metabolism and an increased expression of lactate dehydrogenase B. Cancer Metab. 2019;7:5.","journal-title":"Cancer Metab"},{"key":"571_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-015-0589-8","volume":"32","author":"J Cui","year":"2015","unstructured":"Cui J, Quan M, Jiang W, Hu H, Jiao F, Li N, et al. Suppressed expression of LDHB promotes pancreatic cancer progression via inducing glycolytic phenotype. Med Oncol. 2015;32:143.","journal-title":"Med Oncol"},{"key":"571_CR32","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1073\/pnas.94.2.514","volume":"94","author":"FM Yakes","year":"1997","unstructured":"Yakes FM, Van\u2009Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA. 1997;94:514\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"571_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-2577-y","volume":"11","author":"C Tian","year":"2020","unstructured":"Tian C, Kim YJ, Hali S, Choo O-S, Lee J-S, Jung S-K, et al. Suppressed expression of LDHB promotes age-related hearing loss via aerobic glycolysis. Cell Death Dis. 2020;11:1\u201313.","journal-title":"Cell Death Dis"},{"key":"571_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217353","volume":"611","author":"H Ge","year":"2025","unstructured":"Ge H, Malsiu F, Gao Y, Losmanova T, Blank F, Ott J, et al. Inhibition of LDHB suppresses the metastatic potential of lung cancer by reducing mitochondrial GSH catabolism. Cancer Lett. 2025;611:217353.","journal-title":"Cancer Lett"},{"key":"571_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57463-3","volume":"10","author":"C-Y Huang","year":"2020","unstructured":"Huang C-Y, Yag\u00fce-Capilla M, Gonz\u00e1lez-Pacanowska D, Chang Z-F. Quantitation of deoxynucleoside triphosphates by click reactions. Sci Rep. 2020;10:611.","journal-title":"Sci Rep"},{"key":"571_CR36","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593:586\u201390.","journal-title":"Nature"},{"key":"571_CR37","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/nchembio.2172","volume":"12","author":"Y Chen Jr.","year":"2016","unstructured":"Chen Y Jr., Mahieu NG, Huang X, Singh M, Crawford PA, Johnson SL, et al. Lactate metabolism is associated with mammalian mitochondria. Nat Chem Biol. 2016;12:937\u201343.","journal-title":"Nat Chem Biol"},{"key":"571_CR38","doi-asserted-by":"publisher","first-page":"579464","DOI":"10.3389\/fonc.2020.579464","volume":"10","author":"D Xu","year":"2020","unstructured":"Xu D, Yang H, Schmid RA, Peng R-W. Therapeutic landscape of malignant pleural mesothelioma: collateral vulnerabilities and evolutionary dependencies in the spotlight. Front Oncol. 2020;10:579464","journal-title":"Front Oncol"},{"key":"571_CR39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2405231121","volume":"121","author":"F Novelli","year":"2024","unstructured":"Novelli F, Yoshikawa Y, Vitto VAM, Modesti L, Minaai M, Pastorino S, et al. Germline BARD1 variants predispose to mesothelioma by impairing DNA repair and calcium signaling. Proc Natl Acad Sci USA. 2024;121:e2405231121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"571_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57906-3","volume":"16","author":"H Deng","year":"2025","unstructured":"Deng H, Zhao L, Ge H, Gao Y, Fu Y, Lin Y, et al. Ubiquinol-mediated suppression of mitochondria-associated ferroptosis is a targetable function of lactate dehydrogenase B in cancer. Nat Commun. 2025;16:2597.","journal-title":"Nat Commun"},{"key":"571_CR41","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3390\/pharmaceutics16081015","volume":"16","author":"C Favaron","year":"2024","unstructured":"Favaron C, Gaiaschi L, Casali C, De Luca F, Gola F, Cavallo M, et al. Unraveling novel strategies in mesothelioma treatments using a newly synthetized platinum(IV) compound. Pharmaceutics. 2024;16:1015.","journal-title":"Pharmaceutics"},{"key":"571_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-95633-3","volume":"15","author":"H Deng","year":"2025","unstructured":"Deng H, Malsiu F, Ge H, Losmanova T, Medov\u00e1 M, Zamboni N, et al. LDHB silencing enhances the effects of radiotherapy by impairing nucleotide metabolism and promoting persistent DNA damage. Sci Rep. 2025;15:10897.","journal-title":"Sci Rep"},{"key":"571_CR43","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1158\/1078-0432.CCR-13-0623","volume":"19","author":"JB Dennison","year":"2013","unstructured":"Dennison JB, Molina JR, Mitra S, Gonz\u00e1lez-Angulo AM, Balko JM, Kuba MG, et al. Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancer. Clin Cancer Res. 2013;19:3703\u201313.","journal-title":"Clin Cancer Res"},{"key":"571_CR44","doi-asserted-by":"publisher","first-page":"e0125976","DOI":"10.1371\/journal.pone.0125976","volume":"10","author":"W Sun","year":"2015","unstructured":"Sun W, Zhang X, Ding X, Li H, Geng M, Xie Z, et al. Lactate dehydrogenase B is associated with the response to neoadjuvant chemotherapy in oral squamous cell carcinoma. PLoS ONE. 2015;10:e0125976.","journal-title":"PLoS ONE"},{"key":"571_CR45","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00262-024-03717-2","volume":"73","author":"P Zhang","year":"2024","unstructured":"Zhang P, Wan Y, Ma J, Gong J, Zhong Z, Cui Y, et al. Epigenetic silencing of LDHB promotes hepatocellular carcinoma by remodeling the tumor microenvironment. Cancer Immunol, Immunother. 2024;73:127.","journal-title":"Cancer Immunol, Immunother"},{"key":"571_CR46","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.3892\/ol.2015.2931","volume":"9","author":"L Feng","year":"2015","unstructured":"Feng L, E LL, Soloveiv MM, Wang DS, Zhang BO, Dong YW, Liu HC, et al. Synergistic cytotoxicity of cisplatin and Taxol in overcoming Taxol resistance through the inhibition of LDHA in oral squamous cell carcinoma. Oncol Lett. 2015;9:1827\u201332.","journal-title":"Oncol Lett"},{"key":"571_CR47","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1126\/science.aaa1299","volume":"347","author":"N Sada","year":"2015","unstructured":"Sada N, Lee S, Katsu T, Otsuki T, Inoue T. Epilepsy treatment. Targeting LDH enzymes with a stiripentol analog to treat epilepsy. Science. 2015;347:1362\u20137.","journal-title":"Science"},{"key":"571_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00820-7","volume":"11","author":"S Shibata","year":"2021","unstructured":"Shibata S, Sogabe S, Miwa M, Fujimoto T, Takakura N, Naotsuka A, et al. Identification of the first highly selective inhibitor of human lactate dehydrogenase B. Sci Rep. 2021;11:21353.","journal-title":"Sci Rep"}],"container-title":["Oncogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41389-025-00571-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-025-00571-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-025-00571-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:17:10Z","timestamp":1757377030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41389-025-00571-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["571"],"URL":"https:\/\/doi.org\/10.1038\/s41389-025-00571-4","relation":{},"ISSN":["2157-9024"],"issn-type":[{"value":"2157-9024","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Mouse studies were conducted in compliance with the guidelines and protocols approved by the Institutional Animal Care and Ethical Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"28"}}